Nemaura Medical Probability of Future Pink Sheet Price Finishing Over 0.93
| NMRDDelisted Stock | USD 0.93 0.01 1.06% |
Nemaura |
Nemaura Medical Target Price Odds to finish over 0.93
The tendency of Nemaura Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.93 | 90 days | 0.93 | about 14.4 |
Based on a normal probability distribution, the odds of Nemaura Medical to move above the current price in 90 days from now is about 14.4 (This Nemaura Medical probability density function shows the probability of Nemaura Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Nemaura Medical has a beta of -0.12. This indicates as returns on the benchmark increase, returns on holding Nemaura Medical are expected to decrease at a much lower rate. During a bear market, however, Nemaura Medical is likely to outperform the market. Additionally Nemaura Medical has an alpha of 0.3399, implying that it can generate a 0.34 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Nemaura Medical Price Density |
| Price |
Predictive Modules for Nemaura Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nemaura Medical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Nemaura Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Nemaura Medical is not an exception. The market had few large corrections towards the Nemaura Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Nemaura Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Nemaura Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.34 | |
β | Beta against Dow Jones | -0.12 | |
σ | Overall volatility | 0.16 | |
Ir | Information ratio | 0.05 |
Nemaura Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Nemaura Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Nemaura Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Nemaura Medical is not yet fully synchronised with the market data | |
| Nemaura Medical has some characteristics of a very speculative penny stock | |
| Nemaura Medical has a very high chance of going through financial distress in the upcoming years | |
| Nemaura Medical currently holds 20.03 M in liabilities. Nemaura Medical has a current ratio of 0.97, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nemaura Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Nemaura Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nemaura Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nemaura to invest in growth at high rates of return. When we think about Nemaura Medical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 77.04 K. Net Loss for the year was (14.14 M) with loss before overhead, payroll, taxes, and interest of (1.48 M). | |
| Nemaura Medical currently holds about 14.75 M in cash with (8.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.61. | |
| Roughly 48.0% of the company outstanding shares are owned by corporate insiders |
Nemaura Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Nemaura Pink Sheet often depends not only on the future outlook of the current and potential Nemaura Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nemaura Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 24.9 M | |
| Cash And Short Term Investments | 10.1 M |
Nemaura Medical Technical Analysis
Nemaura Medical's future price can be derived by breaking down and analyzing its technical indicators over time. Nemaura Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Nemaura Medical. In general, you should focus on analyzing Nemaura Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Nemaura Medical Predictive Forecast Models
Nemaura Medical's time-series forecasting models is one of many Nemaura Medical's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Nemaura Medical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Nemaura Medical
Checking the ongoing alerts about Nemaura Medical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Nemaura Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Nemaura Medical is not yet fully synchronised with the market data | |
| Nemaura Medical has some characteristics of a very speculative penny stock | |
| Nemaura Medical has a very high chance of going through financial distress in the upcoming years | |
| Nemaura Medical currently holds 20.03 M in liabilities. Nemaura Medical has a current ratio of 0.97, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nemaura Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Nemaura Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nemaura Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nemaura to invest in growth at high rates of return. When we think about Nemaura Medical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 77.04 K. Net Loss for the year was (14.14 M) with loss before overhead, payroll, taxes, and interest of (1.48 M). | |
| Nemaura Medical currently holds about 14.75 M in cash with (8.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.61. | |
| Roughly 48.0% of the company outstanding shares are owned by corporate insiders |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Nemaura Pink Sheet
If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |